γδ T Cell - Creative Biolabs

Global Services

Comprehensive Quality Professional

T cell-based immunotherapy, especially CAR-T therapy, has made remarkable breakthroughs in tumor therapy. Recently, a special subgroup of "unconventional" T lymphocytes, γδ T cell, has attracted extensive attention in terms of tumor and cancer treatment all through the world.

Over more than 10 years' exploration and expansion, the accumulated experience and abundant expertise have impelled Creative Biolabs to be a leading service provider of novel drug discovery & development. Aiming to fully support customers and advance the development of T cell immunotherapy, Creative Biolabs provides diverse portfolios of high-quality γδ T cell products and a series of tailored γδ T cell-based drug discovery services to worldwide customers.